EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C24H30O5 |
| Net Charge | 0 |
| Average Mass | 398.499 |
| Monoisotopic Mass | 398.20932 |
| SMILES | [H][C@]12c3cccc(CCCC(=O)O)c3O[C@@]1([H])C[C@@H](O)[C@]2([H])/C=C/[C@@H](O)C(C)CC#CC |
| InChI | InChI=1S/C24H30O5/c1-3-4-7-15(2)19(25)13-12-17-20(26)14-21-23(17)18-10-5-8-16(24(18)29-21)9-6-11-22(27)28/h5,8,10,12-13,15,17,19-21,23,25-26H,6-7,9,11,14H2,1-2H3,(H,27,28)/b13-12+/t15?,17-,19+,20+,21-,23-/m0/s1 |
| InChIKey | CTPOHARTNNSRSR-APJZLKAGSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Biological Role: | prostaglandin receptor agonist An agonist that binds to and activates prostaglandin receptors. |
| Applications: | platelet aggregation inhibitor A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. anti-inflammatory agent Any compound that has anti-inflammatory effects. vasodilator agent A drug used to cause dilation of the blood vessels. anticoagulant An agent that prevents blood clotting. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| beraprost (CHEBI:135633) has role anti-inflammatory agent (CHEBI:67079) |
| beraprost (CHEBI:135633) has role anticoagulant (CHEBI:50249) |
| beraprost (CHEBI:135633) has role antihypertensive agent (CHEBI:35674) |
| beraprost (CHEBI:135633) has role platelet aggregation inhibitor (CHEBI:50427) |
| beraprost (CHEBI:135633) has role prostaglandin receptor agonist (CHEBI:66900) |
| beraprost (CHEBI:135633) has role vasodilator agent (CHEBI:35620) |
| beraprost (CHEBI:135633) is a enyne (CHEBI:59831) |
| beraprost (CHEBI:135633) is a monocarboxylic acid (CHEBI:25384) |
| beraprost (CHEBI:135633) is a organic heterotricyclic compound (CHEBI:26979) |
| beraprost (CHEBI:135633) is a organic molecular entity (CHEBI:50860) |
| beraprost (CHEBI:135633) is a racemate (CHEBI:60911) |
| beraprost (CHEBI:135633) is a secondary alcohol (CHEBI:35681) |
| beraprost (CHEBI:135633) is a secondary allylic alcohol (CHEBI:134396) |
| beraprost (CHEBI:135633) is conjugate acid of beraprost(1−) (CHEBI:156557) |
| Incoming Relation(s) |
| beraprost(1−) (CHEBI:156557) is conjugate base of beraprost (CHEBI:135633) |
| IUPAC Name |
|---|
| 4-{(1R,2R,3aS,8bS)-2-hydroxy-1-[(1E,3S)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl]-2,3,3a,8b-tetrahydro-1H-benzo[b]cyclopenta[d]furan-5-yl}butanoic acid |
| INNs | Source |
|---|---|
| beraprost | WHO MedNet |
| beraprost | WHO MedNet |
| béraprost | WHO MedNet |
| beraprostum | WHO MedNet |
| Synonyms | Source |
|---|---|
| MDL 201229 | ChemIDplus |
| MDL-201229 | ChemIDplus |
| MDL201229 | ChEBI |
| ML 1229 | ChemIDplus |
| ML-1229 | ChemIDplus |
| ML1229 | ChEBI |
| Citations |
|---|